Clinical Trial Update: Pancreatitis CytoSorbents (CytoSorb®) Inflammatory Cytokine Removal [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating CytoSorb for inflammatory cytokine removal in acute pancreatitis and systemic inflammatory response syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis
• Systemic Inflammatory Response Syndrome

Drugs mentioned

• CytoSorb

Snippet

Sponsor: Technical University of Munich | Conditions: Pancreatitis, Acute, SIRS | Phase 4 | Status: UNKNOWN